Walleye Trading
AUPH icon

Walleye Trading’s Aurinia Pharmaceuticals AUPH Stock Holding History

Walleye Trading’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,200
Closed -$91.9K – 3977
2026
Q1 		$91.9K Sell
6,200
-13,700
-69% -$200K ﹤0.01% 3486
2025
Q4 		$317K Buy
+19,900
New +$282K ﹤0.01% 3117
2024
Q2 		– Sell
-300
Closed -$1.5K – 4263
2024
Q1 		$1.5K Buy
300
+200
+200% +$1.36K ﹤0.01% 4556
2023
Q4 		$899 Sell
100
-200
-67% -$1.65K ﹤0.01% 4924
2023
Q3 		$2.33K Buy
+300
New +$2.93K ﹤0.01% 4761
2023
Q2 		– Sell
-800
Closed -$8.77K – 4694
2023
Q1 		$8.77K Buy
+800
New +$7.05K ﹤0.01% 4390
2022
Q4 		– Sell
-1,300
Closed -$10K – 4950
2022
Q3 		$10K Buy
+1,300
New +$11.3K ﹤0.01% 4539
2022
Q2 		– Sell
-1,000
Closed -$12K – 5102
2022
Q1 		$12K Buy
+1,000
New +$15.5K ﹤0.01% 4891
2021
Q4 		– Sell
-8,900
Closed -$197K – 5334
2021
Q3 		$197K Buy
8,900
+4,100
+85% +$65.1K ﹤0.01% 3860
2021
Q2 		$62K Buy
4,800
+2,800
+140% +$35.7K ﹤0.01% 4546
2021
Q1 		$26K Buy
+2,000
New +$29K ﹤0.01% 4488
2020
Q1 		– Sell
-11,700
Closed -$237K – 3970
2019
Q4 		$237K Buy
11,700
+1,700
+17% +$15.7K ﹤0.01% 3037
2019
Q3 		$53K Buy
+10,000
New +$60.5K ﹤0.01% 3549

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Trading's AUPH Position: Q2 2026 in Review

Walleye Trading sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 4,236 shares — an estimated $62.8K sold.

Walleye Trading first reported a position in AUPH in Q2 2019 and held it in 14 quarters. The position peaked at $1.74M in Q3 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Walleye Trading reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 4,236 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $62.8K.
  • Walleye Trading first reported a position in Aurinia Pharmaceuticals in Q2 2019 and held it in 14 quarters.
  • Walleye Trading's Aurinia Pharmaceuticals position peaked at $1.74M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.